Japanese Cancer Drug Side Effect: Possible Pituitary Disorder

The Japan Times reports that a cancer drug called Opdivo will now have to carry a warning in Japan about possible links to pituitary disorders after the death of a patient. The drug has not been blamed for the death but the Japanese Health Ministry has ordered that a warning be added to the packaging. The drug, which is in use in the United States and many other countries, is used to fight metastatic melanoma, squamous non-small cell lung cancer, renal cell carcinoma and small cell lung cancer. Read more: https://www.japantimes.co.jp/news/2019/05/10/national/science-health/japan-health-ministry-orders-ono-pharmaceutical-add-warning-opdivo-cancer-drug-death/#.XNirII5KhPY

Print

Available Now!

PPRG6-500 Cover
The Pituitary Patient Resource Guide Sixth Edition is now available! Be one of the first to have the most up-to-date information. The Pituitary Patient Resource Guide a one of a kind publication intended as an invaluable source of information not only for patients but also their families, physicians, and all health care providers. It contains information on symptoms, proper testing, how to get a diagnosis, and the treatment options that are available. It also includes Pituitary Network Association's patient resource listings for expert medical care.

Buy Now